{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:12:57Z","timestamp":1778926377861,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["08391052110002"],"award-info":[{"award-number":["08391052110002"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.breast.2026.104781","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:03:45Z","timestamp":1775307825000},"page":"104781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevalence of cardiac dysfunction and longitudinal changes in cardiac function after breast cancer treatment with chemotherapy with\/without radiation therapy compared with controls"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3894-398X","authenticated-orcid":false,"given":"L.T.","family":"van der Wal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.W.M.C.","family":"Maass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9240-0199","authenticated-orcid":false,"given":"M.R.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H.","family":"Blanker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.P.G.","family":"Crijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Gietema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3104-4471","authenticated-orcid":false,"given":"G.H.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Brandenbarg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.breast.2026.104781_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.breast.2026.104781_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.canep.2012.02.007","article-title":"The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality","volume":"36","author":"Youlden","year":"2012","journal-title":"Cancer Epidemiology"},{"issue":"6","key":"10.1016\/j.breast.2026.104781_bib4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jamaoncol.2020.7468","article-title":"Association of breast cancer irradiation with cardiac toxic effects: a narrative review","volume":"7","author":"Meattini","year":"2021","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104781_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.hfc.2018.08.007","article-title":"Breast cancer and heart failure","volume":"15","author":"Almuwaqqat","year":"2019","journal-title":"Heart Fail Clin"},{"issue":"3","key":"10.1016\/j.breast.2026.104781_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4048\/jbc.2024.0085","article-title":"Breast cancer and therapy-related cardiovascular toxicity","volume":"27","author":"Hwang","year":"2024","journal-title":"J Breast Cancer"},{"issue":"11","key":"10.1016\/j.breast.2026.104781_bib7","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer."},{"issue":"8","key":"10.1016\/j.breast.2026.104781_bib8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.breast.2026.104781_bib9","first-page":"869","article-title":"Chemotherapy-induced cardiotoxicity: detection, prevention, and management","volume":"30","author":"Truong","year":"2014","journal-title":"Can J Cardiol"},{"issue":"36","key":"10.1016\/j.breast.2026.104781_bib10","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European society of cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.breast.2026.104781_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2017.05.013","article-title":"Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: a cross-sectional study","volume":"81","author":"Boerman","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2026.104781_bib12","series-title":"ICPC: international classification of primary care","author":"Lamberts","year":"1987"},{"issue":"1","key":"10.1016\/j.breast.2026.104781_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of Echocardiography and the European association of cardiovascular imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"10.1016\/j.breast.2026.104781_bib14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European Association of cardiovascular imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.breast.2026.104781_bib15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","volume":"18","author":"Galderisi","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.breast.2026.104781_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ejhf.1610","article-title":"Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years","volume":"22","author":"Jacobse","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.breast.2026.104781_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10549-015-3454-8","article-title":"Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer","volume":"152","author":"Caram","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2026.104781_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.23.01779","article-title":"Cardiac dysfunction among breast cancer survivors: role of cardiotoxic therapy and cardiovascular risk factors","volume":"43","author":"Bostany","year":"2025","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2026.104781_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"10","author":"Nagueh","year":"2009","journal-title":"Eur J Echocardiogr"},{"issue":"2","key":"10.1016\/j.breast.2026.104781_bib20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijrobp.2019.02.003","article-title":"Cardiac function after radiation therapy for breast cancer","volume":"104","author":"van den Bogaard","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.breast.2026.104781_bib21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ehjci\/jex252","article-title":"Impact of the 2016 ASE\/EACVI recommendations on the prevalence of diastolic dysfunction in the general population","volume":"19","author":"Almeida","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626000913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626000913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:58:40Z","timestamp":1778925520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977626000913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":20,"alternative-id":["S0960977626000913"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104781","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of cardiac dysfunction and longitudinal changes in cardiac function after breast cancer treatment with chemotherapy with\/without radiation therapy compared with controls","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104781"}}